BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 10, 2011 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a clinical-stage biopharmaceutical company focused on cardiovascular disease today announced that it is scheduled to participate in two upcoming investor conferences: the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15, 2011 and the Citi 8th Annual U.S. Small/Mid Cap Conference also on Tuesday, November 15, 2011.
